Diabetes, HCV new growth pillars for BMS in Japan
This article was originally published in Scrip
Executive Summary
Like many of its multinational peers, Bristol-Myers Squibb is bullish on its expansion prospects in Japan despite being hit by major patent expiries elsewhere, driven by the timely launch of new products on the back of simultaneous global development programs and speedier regulatory procedures.